A Cross-sectional Study to Evaluate the Prevalence of HPV in Gay and Bisexual Men Aged 21-25 Years in Australia
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Prevalence of type-specific HPV types
研究概览
简要总结
Anal cancer is overrepresented among gay, bisexual and other men who have sex with men (MSM), particularly those living with HIV. Australia was the first country to introduce a publicly funded national HPV vaccination program in 2007. This program was expanded to include schoolboys aged 12-13 years in 2013; with a 2-year catch-up for boys aged up to 15 years.
The goal of the HYPER4 study is to determine the prevalence of anal, genital and oral HPV among 500 young gay and bisexual men aged 21-25 years who were eligible for the school-based gender-neutral quadrivalent vaccination program.
Participants will be required to complete a questionnaire and provide samples for HPV testing. No follow-up visits will be required.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 21 Years 至 25 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Men aged 21 to 25 years old in 2023-2024
- •Same-sex attracted
- •Residing in Australia since 2013
排除标准
- •Unable to complete all study requirements in English
结局指标
主要结局
Prevalence of type-specific HPV types
时间窗: Baseline
The oral, penile and anal prevalence of type-specific HPV types
Prevalence of quadrivalent vaccine HPV types
时间窗: Baseline
The oral, penile and anal prevalence of quadrivalent vaccine types (6, 11, 16 and 18)
次要结局
未报告次要终点
研究者
Eric Chow
Associate Professor
Monash University